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ABSTRACT  
 
    In the chronic infections caused by Salmonella enterica Typhimurium; bacteria reside in places 
such as mesenteric lymph nodes, spleen or liver (Monack, Bouley & Falkow, 2004). Chronic 
carriers do not show the disease symptoms but can still transmit it to others by shedding in stools 
as a major mechanism in spreading the disease (Griffin & McSorley, 2011). Single point 
mutation in ptsN (ptsN-SNP) gene resulted in complete dominancy over the wild type version of 
the gene in S.Typhimurium during chronic infection of mice. It is believed that the protein 
encoded by ptsN (EIIA
Ntr
) is involved in transport of phosphoryl group in sugar metabolism, 
nitrogen metabolism, or as lately research suggests in potassium metabolism. Specifically for 
Salmonella, EIIA
Ntr
 was found to interact with SsrB, what resulted in negative regulation of the 
gene expression from Salmonella pathogenicity island 2 (Choi et al., 2010). Using BACTH 
system we aimed to investigate interaction between EIIA
Ntr
-SNP and SsrB. However, our results 
do not indicate the interaction of SsrB with neither EIIA
Ntr
-SNP nor EIIA
Ntr
.  
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INTRODUCTION 
 
Salmonella and its pathogenicity 
    The name Salmonella refers to a genus name classified under the Enterobacteriaceae family 
that are characterized by being gram-negative, rod shaped and facultative anaerobic bacteria. 
They are responsible for food borne diseases caused by eating contaminated food that affected 
human population severely in recent years (Fabrega & Vila, 2013).  S. bongori and S. enterica are 
the two species of this genus, the former has one subspecies and the latter has seven subspecies 
with over 2,500 serovars (Garai, Gnanadhas & Chakravortty, 2012; Porwollik & McClelland, 
2003). Those two species and their subspecies differ in their host ranges such that S. bongori and 
S. enterica infects mainly cold blooded animals, aside from serovars of S. enterica subspecies 1 
which have further divisions in warm blooded animal hosts. While S. enterica serovar 
Typhimurium has a broader host range including humans, bovine and rodents, S. enterica serovar 
Typhi has a narrower host range infecting humans and higher primates only (Porwollik & 
McClelland, 2003). 
    Salmonella is an intracellular pathogen and gained its virulence factors by horizontal gene 
transfer throughout evolution. Many gene products are accounted for the survival of the bacteria 
in the host cell, more specifically Salmonella pathogenicity islands (SPI). SPIs, located within the 
Salmonella chromosome, establish specific interactions with the host and contribute to a 
particular virulence phenotype which is manifested at a precise time during the infection.  
Figure 1. Location of SPIs genes in 
Salmonella genome. 
[figure source: MOH Key Laboratory of 
Systems Biology of Pathogens, 
Institute of Pathogen Biology, Virulence 
factors of pathogenic bacteria. 
(http://www.mgc.ac.cn/cgi-
bin/VFs/genus.cgi?Genus=Salmonella) 14 
April 2015] 
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    Among more than twenty identified SPIs, location of five is shown in Figure 1, of which,   
SPI-1 required for bacterial invasion and SPI-2 for growth and survival of the bacteria in the host 
cell (Hapfelmeier et al., 2005; Eswarappa et al., 2008). To do so, Salmonella encodes type III 
secretion systems (T3SS) with virulence phenotype that delivers virulence proteins or effectors 
into the host cell. Many bacterial pathogens use T3SS for delivery of virulence phenotypes and to 
interrupt cell signaling pathways. SPI-1 contains 29 genes that encode T3SS, including its 
regulators and effectors. The injection of effectors through a needle-like secretion system allows 
the pathogen to enter non-phagocytic cell and colonize in the intestine (Marcus et al., 2000). 
Once inside the host, Salmonella carries on its intracellular life cycle by staying in a special 
compartment which is bound to the membrane, called Salmonella containing vacuole (SCV) 
(Dandekar et al., 2012).  SPI-2 contains more than 40 genes, including a two-component 
regulatory system (SsrA/B) and T3SS. Similar to the previous pathogenicity island, the secretion 
system that is encoded by SPI-2, is shaped like a needle which injects effectors (for example 
SseK2 and SseI) into the host cell's cytosol (Fig. 2) or into the SCV which contributes to the 
survival and replication of the pathogen. Indeed, SseK2 is required mainly for intercellular 
growth and SseI effectors maintain a persistent infection. These two effectors are required for late 
stages of the infection (Ruby et al., 2012). 
 
Figure 2. Type three secretion 
system and effectors encoded 
by SPI-2. 
(Marcus et al., 2000) 
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    Salmonella infections may lead to gastroenteritis, typhoid fever or non-typhoidal Salmonellesis 
(NTS). Studies on mice infection confirmed that once taken orally, Salmonella goes to the small 
intestine and penetrates through the epithelial cells lining the intestines by T3SS. Salmonella 
destroys epithelial cells by bursting their mitochondria and this leads to loss of membrane 
integrity. In this way, the bacteria gains access to enterocytes (Jones, Ghori & Falkow, 1994). 
Once access to intestinal lymphoid tissues is made possible through damaged epithelial cells, 
Salmonella penetrates through mesenteric lymph nodes (MLNs) (Moon & McSorley, 2010). 
From there, it travels by blood to the systemic tissues and then to the spleen and liver (McSorley 
et al., 2002). This infection pathway is observed in murine models and gives clues about the 
systemic infections which lead to typhoid fever in human patients caused by S. enterica serovar 
Typhi. However, there are some cases where Salmonella resides in the hosts without making 
them ill. After systemic infection by S. Typhi, approximately 1-5% of the infected individuals 
become chronic carriers of this disease especially residing in the gall bladder (WHO, 2003). In 
this chronic infection case of typhoid fever; carriers do not show the symptoms of the disease 
such as damages in intestines or fever but can still transmit the disease via shedding (Griffin & 
McSorley, 2011). This chronic carrier state is essential to study from microbiological point of 
view to understand the ways that bacteria use in order to survive in the host for longer periods of 
time. In addition, since S. Typhi is a human restricted pathogen, chronic carriers are the main 
entities to transmit the disease (Bhan, Bahl & Bhatnagar, 2005). 
 To understand the bacterial mechanisms to stay in host for long periods of time, 
experiments are being done on mice typhoid cases. As mentioned above, SseI is an essential 
effector for the systemic and persistent infections and studies confirmed that it prevents 
macrophages and dendritic cells (DCs) from migrating to other sites and disrupts their ability to 
communicate with the immune system. By this way, host's immune system is reduced in the 
sense of its ability to clear bacteria in different tissues such as spleen (McLaughlin et al., 2009; 
Ruby et al., 2012). Disrupting the cell migration of the host is one of the significant strategies that 
Salmonella uses to sustain the host's immune system. Another important factor that contributed to 
the persistent infection was found to be the microbiota of the intestines suggesting that some 
microorganisms in intestines might inhibit the proliferation of Salmonella (Lawley et al., 2008). 
Further studies were carried out to understand the sites in body where the bacteria reside. Mice 
infected by S. Typhimurium showed that in chronic infections, the pathogen persists in MLNs, 
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liver and spleen. MLNs were found to be the most common reservoir of bacteria in chronic 
infections where bacteria can stay for one year in macrophages of systemic tissues. (Monack, 
Bouley & Falkow, 2004). The other common site for Salmonella persistence was found to be the 
gallbladder where they can form biofilms either on gallstones or the on the epithelium of this 
organ (Escebado & Gunn, 2013). 
SsrA/B system 
    SsrB is a protein, encoded by a gene called ssrB, takes part in a two component system SsrA/B 
which has been mentioned earlier. It controls the expression of the genes in SPI-2, which also 
contains the ssrB gene itself, very effectively. The other component of the system is SsrA 
encoded by a gene called ssrA (Walthers et al., 2007) Members of two component regulatory 
system work together by interacting with each other to provide bacteria an adaptive response to 
the changes in the environment.  
    The first component of two component regulatory system is a transmembrane Histidine Kinase 
which gets auto-phosphorylated as a change has occurred in the environment. In SsrA/B system, 
SsrA acts as the sensor kinase and it starts the response mechanism. The next step is to transfer 
the phosphoryl group from SsrA to the response regulator which is SsrB, in this case. When SsrB 
gets phosphorylated it has high affinity for DNA binding, therefore it can regulate the expression 
of SPI-2 virulence genes (Feng, Oropeza & Kenney, 2003). SsrA/B system can respond to some 
physiological signals from the environment such as acidic pH, low osmolarity and the absence of 
Ca
2+
. (Garmendia, Beuzon, Ruiz-Albert & Holde, 2003) Sensation of low pH, low osmolarity and 
low Ca
2+
 concentration indicates that the bacterium is in a host, thus, it should activate its 
pathogenicity island to start an infection. In addition to positively regulatory effect of SsrB on the 
expression of SPI-2 genes, there are also proteins that repress the activity of SPI-2 genes. Their 
mechanism is dependent on silencing the ssrB genes as it is the main mechanism for controlling 
SPI-2.  
    In addition to positive auto-regulation of SsrB, there are many other factors that control SsrB 
activation depending on some environmental factors. Another two component system, OmpR-
EnvZ, is responsible for regulation of SsrA/B proteins. At normal pH around 7.4, SsrB levels 
drop as OmpR levels decreases. This suggests that at cellular pH, OmpR-EnvZ two component 
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system can activate the transcription of SsrA/B system. (Feng, Walthers, Oropeza & Kenney, 
2004) 
ptsN and its product, EIIA
Ntr
 
    ptsN (in some literature found as nagE) is a gene found in various of bacteria species, which 
encodes for protein involved in phosphotransferase system (PTS). Proteins encoded by ptsN are 
involved either in sugar transport (subunit IIA) or regulation of nitrogen metabolism (protein 
EIIA
Ntr
). However, recent studies suggest that EIIA
Ntr 
may have different functions than 
previously proposed. However, Reaves and Rabinowitz states that the ptsN gene is not involved 
in the regulation of organic nitrogen metabolism, at least in E.coli K-12. Current findings propose 
the role of EIIA
Ntr 
in keeping potassium homeostasis (Reaves and Rabinowitz, 2011; van 
Heeswijk, Wasterhoff & Boogerda, 2013). The real function of EIIA
Ntr
 is not fully understood as 
of yet.  
    Regardless of the unknown function, EIIA
Ntr 
was crystalized in order to obtain its protein 
structure. It is a rather small molecule made of 163 amino acid residues and is 17.9kDa. The 
active site of the protein is histidine 73 (His73), where enzyme receives phosphoryl group and 
pass it further to another enzyme in the system, based on the model obtained from E.coli (Bordo 
et al., 1998). S. Typhimurium ptsN gene express enzyme EIIA
Ntr
, which according to Choi et al. 
(2010) interacts with the SsrB protein by negative regulation of virulence, moreover it is essential 
for Salmonella virulence. Studies suggested that the two interact to regulate the SPI-2 genes and 
experimental results have shown that both lack and overexpression of EIIA
Ntr
 would stunt 
Salmonella virulence. A lack of the EIIA
Ntr
 protein would show a hyper activation of the SPI-2 
genes, which would negatively affect Salmonella virulence, while an overexpression of EIIA
Ntr
 
would drastically decrease the expression of the SPI-2 genes. 
    The results proved that EIIA
Ntr
 was needed for the regulation of SPI-2, and upon further 
analysis, it was determined that EIIA
Ntr
 acts directly on SsrB as a negative control and thus, 
prevents it from binding to its target promotors. A further conclusion to these results suggests that 
the expression of the SPI-2 genes must be kept at a certain level for the Salmonella virulence to 
function regularly. 
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Two hybrid screening  
    A two-hybrid screening is usually associated with the yeast two-hybrid system which consists 
of a DNA bound protein, usually Gal4 binding domain (Gal4 BD), fused with the first protein of 
interest, the “bait”, and a transcription co-regulating protein, usually Gal4 activator domain (Gal4 
AD), fused with the second protein of interest, the “prey”. When Gal4 AD and Gal4 BD interact 
under normal conditions, they express a reporter gene, usually lacZ. If lacZ is not expressed when 
surrounded by the proteins of interest fused with Gal4 AD and Gal4 BD, then it is safe to 
conclude that the “bait” and the “prey” did not bring Gal4 AD and Gal4 BD together and thus do 
not interact under normal conditions (Young K.H., 1998). 
    The BACTH system is very similar, although rather than having DNA bound protein and 
transcription co-regulating protein, it makes use of the catalytic domain of adenylate cyclase 
(CyaA) from Bordetella pertussis which consists of two complementary fragments, T25 and T18, 
expressed from plasmids pKT25 and pUT18C respectively. The two fragments are only active 
when held together physically, and when they are active, they convert adenosine triphosphate 
(ATP) into cyclic adenosine monophosphate (cAMP). The fact that they only interact when held 
together is the key element for the BACTH system to allow the observation of protein 
interactions with cAMP being the interaction signal (Joung, Ramm & Pabo, 2000). 
 
    In order to observe two protein of interest, in this case EIIA
Ntr 
and SsrB, the interaction, or lack 
of interaction, must take place in E. coli cells containing a non-reverting adenylate cyclase 
deficient reporter strain, BTH101 or DHM1 included with the BACTH system kit, due to the 
reporter gene requiring cAMP to be expressed. The proteins of interest must be fused with T25 
and T18 respectively by cloning into pKT25 and pUT18C followed by the genes of interest, ptsN  
(X) and ssrB (Y) respectively as seen in figure 3 below (Eurodemex, n.d.). 
 
Figure 3. Cloning pKT25and pUT18C 
followed by the genes of interest, (X) and (Y) 
respectively. 
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    Once the proteins are fused, the reporter gene will signal when the proteins of interest interact. 
Since the E.coli strain lacks adenylate cyclase activity, production of cAMP would be an 
indicator of interaction between T25 and T18 when the reporter gene is expressed. In this case, it 
can be concluded that the two proteins of interest interact under normal conditions as seen in the 
figure 4. 
 
Figure 4. (A) No interaction takes place, therefore the reporter gene is not expressed. (B) An interaction takes place 
thus, converting ATP into cAMP and therefore the reporter gene is expressed. 
 
    This project has arisen from the interest in investigating whether there is interaction between 
point-mutated EIIA
Ntr
 (EIIA
Ntr
 -SNP) and SsrB detected in the mice sample with Salmonella 
chronic infection. EIIA
Ntr
 -SNP have serine residue at position 21 (Ser21) replaced with arginine 
(Arg21). The mutation was found in clones isolated from the liver and spleen sample of mice, 
especially in liver the EIIA
Ntr
 -SNP almost completely dominated over any other strains (this data 
is given by our supervisor). It is suspected that this mutation causes a change in the regulation or 
activity of Salmonella virulence.  
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MATERIALS AND METHODS 
 
Strains and Growth Conditions  
    According to the BACTH system, in order to detect interaction between our two proteins of 
interest, they should be fused into two fragments, T25 and T18 in bacteria. For this reaction to 
happen, we need vectors expressing the fragments fusion pKT25 and pUT18C respectively. First, 
two genes of interest (ptsN and ssrB) were cloned into the corresponding plasmids to obtain 
pKT25-ptsN and pUT18C-ssrB vectors. These two proteins should interact according to Choi et 
al. Interactions between pKT25-ptsN-SNP and pUT18C-ssrB are not known. Also, there is a 
negative control (pUT18C/pKT25) that should not interact and a positive control (pKT25-
zip/pUT18C-zip) that should interact (Table 1). 
Table 1. 4 bacterial strains used for the two-hybrid system assay. 
Strain pUT18C vector pKT25 vector Interaction 
1 pUT18C pKT25 No interaction (negative control) 
2 pUT18C-zip pKT25-zip Interaction (positive control) 
3 pUT18C-ssrB pKT25-ptsN Interaction (Choi et al., 2010) 
4 pUT18C-ssrB pKT25-ptsN-SNP Not known 
 
    All plasmids should be stored at -20 
o
C. Strains with pUT18C should be grown in LB + 
ampicillin (amp) (100µg/ml) medium whereas strains with pKT25 should be grown in LB + 
kanamycin (kan) (50µg/ml) medium. After the transformation with both vectors, strains should 
be grown in LB + amp + kan medium. In order to clone the two proteins into the fragments, 
vectors were transformed into XL1-blue which is optimized for cloning and contains the 
repressor of the LacZ operon.  
Bacterial strains and their genotypes:  
 BTH101 
Genotype: F-, cya-99, araD139, galE15, galK16, rpsL1(strr), hsdR2,mcrA1, mcrB1 (Euromedex, 
n.d.) 
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 XL1 Blue 
Genotype: Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 
lac [F′ proAB lacIqZΔM15 Tn10 (Tetr)] (Stratagene, 2004) 
 
All strains should be stored at -80
 o
C. 
 
Construction of Strains 
Primers used to obtain desired bacterial strains  
    In order to perform BACTH, the gene for bait protein and the gene for protein of interest were 
integrated into two complementary vectors which are pUT18C and pKT25. Primers were 
designed in a way that they included the entire gene of interest and there was at most 1-2 
o
C 
difference in melting temperatures of forward and reverse primers. Also, 2 restriction sites, 
BamHI and EcoRI were integrated into the primers without disrupting their reading frame. These 
restriction sites were used for ligation with the plasmids later. The restriction sites integrated are 
shown in figure 5. 
Figure 5. Schematic view of plasmids 
maps, adapted from the Euromedex 
BACTH System Kit.  
 
 
 
 
     
    The same primers were used for both pKT25-ptsN and pKT25-ptsN-SNP as they are derived 
from the same gene.  The temperatures for the annealing step were determined as 52
o
C for ssrB 
and 54
o
C for ptsN PCRs. Chromosomal DNA from wild type S. Typhimurium was used as 
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template for ssrB and ptsN PCR whereas chromosomal DNA from ptsN-SNP mutant was used for 
ptsN-SNP PCR. Lengths of PCR-products were 711bp and 561bp for ssrB and ptsN, respectively. 
The protocol for PCR is introduced in Appendix A, Protocol 1. As the last step, PCR products 
were run on an agarose gel to check if they had the correct sizes [see Appendix A: Protocol 2]. 
Table 2. Primers used to obtain bacterial strains. 
Primer Sequence (5’→3’)   Tm(oC) 
ssrB forward 
ssrB reverse 
ptsN forward 
ptsN reverse 
AGGATCCCATGAAAGAATATAAGATCTTATTAGTAGACG 
GGAATTCCGTGGCGTAAGGCTCATC 
AGGATCCCATGATAAATAACGATACGACTCTACAACTG 
GCGAATTCAGTACCATGTACCGTTTCTCCTC 
53,3/61,3 
52,6/61,0 
56,2/63,4 
55,3/63,0 
 
Digestion and Ligation  
    Digestion of PCR products and plasmids was performed according to the protocol [see 
Appendix C: Protocol 1] and incubated for 1 hour at 37
o
C. For digestion of the vectors FastAP 
was added, as alkaline phosphatase (AP) should prevent re-ligation of plasmids by removing 
phosphate groups from the end of DNA-strands. FastAP was added only to vectors, because PCR 
products will “donate” missing phosphate groups.  
    After digestions, both the vectors and PCR products were purified using PureLink® Quick 
PCR Purification Kit [Catalog number K3100-01] and ligations were set up. 4 ligations with 
different ratios for each vector (pUT18C-ssrB, pKT25-ptsN and pKT25-ptsN-SNP) were 
established [see Appendix C: Protocol 2] and incubated for 1 hour at room temperature (RT). 
After, the plasmids were transformed to the XL1-Blue competent cells [see Appendix B: Protocol 
2] and plated with proper antibiotic (amp or kan for pUT18C and pKT25 respectively).  
 
Colony PCR 
    A colony PCR was made in order to confirm that transformation of the vectors with the PCR 
products were made correctly. At first, overnight cultures were streaked (4-6 colonies from each 
ligation ratio) on plates with proper antibiotics. Then, bacterial mass was picked up and lysed at 
13 
 
high temperature, in order to release DNA from the cells. Next, PCR was run according to the 
previously described protocol [see Appendix A: Protocol 1]. [see Appendix C: Protocol 3]. The 
PCR products were run on agarose gel and the ones with more intense bands were selected to use 
later.  
Making Cells Competent and Transformation 
    XL1-Blue and BTH101 cells were made competent by CaCl2 according to the protocol [see 
Appendix B: Protocol 1] to make them able to take up plasmids by transformation. 
    Minipreps of the plasmids pUT18C, pKT25, pUT18C-zip and pKT25-zip were prepared 
according to the protocol using PureLink® Quick Plasmid Miniprep Kit [Catalog number K2100-
10] to obtain purified plasmid DNA. The centrifuge was set to 13400 rpm for this process. 
Transformations were made sequentially. Firstly, 2µl of pUT18C and pUT18C-zip were 
transformed into BTH101 competent cells according to the protocol. [see Appendix B: Protocol 
2] Then, these cells were inoculated to LB amp plates and made competent to proceed to the next 
transformation. Secondly, pKT25 plasmids were transformed into BTH101/pUT18C competent 
cells and pKT25-zip plasmids were transformed into BTH101/pUT18C competent cells 
according to the protocol. The final transformations were inoculated on LB agar plates containing 
both amp and kan. 
    For strain 3 and strain 4, the same transformation procedure was followed. Firstly, pUT18C-
ssrB was transformed into the competent BTH101 cells by adding 2µl miniprep according to the 
protocol. After, pKT25-ptsN and pKT25-ptsN-SNP ligations were transformed into the competent 
BTH101/ pUT18C-ssrB cells. 
 
BACTH System 
    4 strains were prepared according to Appendix B. The BACTH system was performed 
according to BACTH System Kit (Euromedex- EUK001). To observe the outcomes of BACTH, 
two different experiments were performed. The first one is the inoculation of strains to the X-gal 
plates. Preparation of the plate is described in Appendix D, Protocol 1. Secondly, for the 
calculation of β-galactosidase activity, an assay was run according to the protocol [Appendix D, 
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protocol 2] and the formula below was used. In order to be able to calculate the activity, OD 
values for 420nm, 550nm and 600nm were measured with plate reader. Activity results obtained 
were in a special unit called Miller unit.  
Spec. β-galactosidase activity = 1000 * (OD420 - (1.75 * OD550)) / (time * OD600 * ml sample) 
    In this formula, the “ml sample” indicates the volume of cells in the beginning of the assay and 
it was 0.1ml in this experiment. Time is the duration of assay after adding the ONPG solution 
until the assay is stopped with Na2CO3. OD600 was measured in the beginning of assay and it 
indicates the number of cells put in the assay. OD420 is a combination of absorbance values of o-
nitrophenol which is the product from cleavage of ONPG by β-galactosidase, and cell debris. 
Therefore, OD550 - the cell debris is subtracted, from OD420 to find the real enzymatic activity. 
(Miller, 1972) Adding IPTG to the overnight cultures is necessary for lac genes to be expressed, 
since IPTG is similar to lactose in structure and it is used as inducer of lac operon. 
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RESULTS 
 
ptsN mutation and simulation changes in EIIA
Ntr
  protein model 
    EIIA
Ntr 
is a protein with an active residue in His73. Studies did not find the evidence of activity 
of Ser21 residue, where mutation of interest occurred. Therefore firstly, using BLAST engine we 
confirmed the conservation of this amino acid in the peptide sequence. Alignment of the ptsN 
sequence from S. Typhimurium str. ST4/74 (this strain was used for the peptide sequence 
alignment, as that was the strain used in the primary research by our supervisor) ptsN gene and 
ptsN gene of 99 other organisms shown conservation of Ser21 at the level of 91%, remaining 
organism had alanine (Ala21) [Appendix E, Table 1]. Serine is an amino acid with a methyl and 
hydroxyl group on the side chain (Fig. 6A), where alanine is lacking the hydroxyl group (Fig. 
6B). Interestingly, arginine is positively charged with amine group in the side chain (Fig. 6C) and 
had not been found in any organism in the alignment.  
 
Figure 6. Chemical structure of 
three amino acids: serine (A), 
alanine (B) and arginine (C).  
(Picture source: 
http://matznerd.com/wp-
content/uploads/2012/12/amino-
acid-table1.gif 17.04.2015) 
    To identify whether the mutation to Arg had an influence on the protein structure, 
computational models were obtained using accessible online Phyre2 web server, 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index, [08.04.2015]). Amino acid 
sequence of Salmonella ptsN gene and ptsN-SNP was introduced and structural simulation 
models were presented. E.coli EIIA
Ntr
 model from Bordo D. et al. was used automatically as a 
template. 
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Figure 7. Presentation of the structural models of EIIA
Ntr
 in E.coli (A), simulation of the structural model of EIIA
Ntr
 
in Salmonella (B) and simulation of EIIA
Ntr
-SNP the model Salmonella (C). Pictures were generated by using of 
PyMOL. Amino acid of interest is indicated with blue sticks. 
    Figure 7 indicates the position of Ser21 in the protein structure in E.coli and it is indicated with 
blue sticks. Based on this template, Salmonella proteins model were simulated, wild type as well 
as EIIA
Ntr
-SNP. The difference in the amino acid sequence between these two organisms is 8, not 
including Ser21 [Appendix E; Table 2]. Figure 7C shows the mutated protein, where Arg21 
replaces Ser21. In that model positively charged amino acid is folded “inside” the protein. 
However, this scenario is predicted by Phyre2 as wrong, model says Arg should not be placed on 
the position 21, because it disrupts the structure when it is placed towards the inside of protein. 
    Computer modeling says it is unlikely that this mutation would occur, nevertheless it occurred 
in real life. One explanation could be that EIIA
Ntr
-SNP protein has Arg folded outside rather than 
inside, making it protruded. In some way this mutation is favorable for bacteria, however without 
experimental results there are only speculations of how and what it exactly does. 
 
Cloning of the BACTH plasmids 
    In order to investigate the interaction between EIIA
Ntr
-SNP and SsrB, following BACTH 
strains had been constructed: pUT18C-ssrB/ pKT25-ptsN and pUT18C-ssrB/pKT25-ptsN-SNP. 
To this end gene regions were PCR amplified as described in Material and Methods section.  
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   PCR results (Fig. 8A) shown bands of expected size for ssrB, ptsN and ptsN-SNP, 
approximately 711 bp, 561 bp and 561 bp, respectively. PCR products ligated with the adequate 
plasmids were transformed to XL1-Blue strain. Plated clones with different ligation ratios are 
shown in Appendix B. In order to confirm transformation of plasmids with inserted genes, colony 
PCR was performed (Fig. 8B, C). Absence of the gene in colony PCR indicates unsuccessful 
ligation of vector and gene, due to the different ratios used. Samples indicating presence of the 
gene of interest: ptsN sample 4, ptsN-SNP sample 2 and 3, ssrB sample 8 and 11; were used for 
miniprep preparation and strains construction. Colony PCR for ssrB gene did not show any bands 
at first, therefore it was decided to change annealing temperature from 52
o
C to 61
o
C. Agarose gel 
indicating presence of ssrB is shown in figure 8C. 
BACTH results 
    To observe the outcomes of BACTH two different methods are used. In order to observe the 
presence of interaction between proteins, β-galactosidase activites were measured. If two proteins 
were interacting, it would start the accumulation of cAMP, which will result in the fusion 
between cAMP responsive promoter and lacZ promoter. Thus, measuring β-galactosidase activity 
with spectrophotometer is a good indicator of the presence of interaction. In this process, the 
outcome was calculated by a formula to obtain activity in Miller units. The second method used 
to determine the interaction was the inoculation of strains to the X-gal plates. In this process, 
cells that have the β-galactosidase activity would cleave X-gal and this would result in formation 
of blue colonies. On the other hand, the ones that lack β-galactosidase activity, cannot metabolize 
X-gal, would form white colonies on the plate. 
   In the first trial of experiment, the activity results on the Appendix F, Table 1 are obtained. 
Also, figure 9 shows the color formation on X-gal plate after overnight incubation at 30
o
C. As 
can be seen from the plate, none of the strains formed blue colonies. All the strains formed white 
colonies, meaning that they did not have β-galactosidase activity. There are some very pale blue 
colonies but they are not trustable results.  
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Figure 8. PCR and colony PCR results run in agarose gel. (A) indicates the three genes of interest: ssrB, ptsN and 
ptsN-SNP. (B) shows clones samples with ptsN or ptsN-SNP and purified ptsN and ptsN-SNP used as a control. (C) 
indicates second trail for colony PCR for ssrB with changed annealing temperature. All gels were loaded with the 
same DNA ladder and bands of the genes of interest were found between 500 and 1000 bp, as expected. 
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Figure 9. Resulting strains inoculated on X-gal plates. # 
indicates the number of strain and the full names of strains 
are as follows: #1 is negative control (pUT18C/pKT25), #2 
is positive control (pUT18C-zip/pKT25-zip), #3 is the 
strain with gene of interest, pUT18C-ssrB/pKT25-ptsN and 
#4 is the mutated strain, pUT18C-ssrB/pKT25-ptsN-SNP. 
 
 
 
 
Reading from the first trial did not show the expected pattern in which negative controls would 
have low activity, whereas positive controls would have high activity [Appendix F, Table 2]. It 
was concluded that these results were not correct, therefore another attempt for the experiment 
was made. For the second trial, protocol was changed to increase the induction with IPTG. Also, 
the overnight incubation temperature was decreased to 30
o
C. During the overnight incubation, 
IPTG was introduced into the media so there was no need for steps 2-5 [see Appendix D, 
Protocol 2]. In addition to these changes, strains were prepared again because they were 
suspected to be prepared wrong for the first trial. Along with all these changes, more reliable 
results were obtained from the second trial. Because β-galactosidase activity was observed for 
positive control and not for the negative controls, it was confirmed that the assay was working 
well. The activity results for second trial are given in Appendix F, Table 2. 
Figure 10. Resulting strains inoculated on 
X-gal plates. # indicates the number of 
strain and the full names of strains are as 
follows: #1 is negative control 
(pUT18C/pKT25), #2 is positive control 
(pUT18C-zip/pKT25-zip), #3 is the strain 
with gene of interest, pUT18C-
ssrB/pKT25-ptsN and #4 is the mutated 
strain, pUT18C-ssrB/pKT25-ptsN-SNP. 
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    Figure 10 shows the resulting colony colors of the strains after 2 days incubation on X-gal 
plates with IPTG at 30
o
C. Positive control (pUT18C-zip/pKT25-zip) was the only strain that 
gained the blue color. It was expected to be a darker blue, still we can say that positive control 
has the β-galactosidase activity. Other strains formed white colonies indicating that they could 
not metabolize X-gal, they did not have β-galactosidase activity. These results were correlated 
with results of β-galactosidase assay that was performed later.  
 
Figure 11. β-galactosidase activities of samples measured and calculated according to protocol. 
    As shown in figure11, most of the strains had very low β-galactosidase activities except strain 
2 which was the positive control. It was expected that strain 1, negative control, would have a 
very low activity due to lack of interaction of proteins. Among all the samples, strain 4 had the 
lowest activity, 1.59 in average. As Choi et al. proved that there is interaction between pUT18C-
ssrB and pKT25-ptsN, thus strain 3 should have high β-galactosidase activity (Choi et. al., 2010). 
Despite the fact that it was expected that strain 3 would have a high activity likewise strain 2, it 
had very low activity, 1.81 in average. Other than that, the same correlation between the positive 
and negative controls is observed in the experiment. 
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   To confirm the presence of genes in the constructed plasmids for strain 3 and 4, colony PCR 
was performed (Fig. 12). Two samples from each plate were taken and shown the presence of 
ssrB, ptsN and ptsN-SNP. 
 
Figure 12.Colony PCR of strains 3 and 4, in order to confirm gene presence. ssrB sample 1 and two are taken from 
strain 3, sample 3 and 4 are taken from strain 4. Previously purified PCR products were used as a reference for the 
gene weight.  
   The results obtained from the second trial (Fig. 11) were convenient with the expectations in 
terms of results of the positive and negative controls. Also, the same pattern was observed in 
terms for both biological replicates. Thus, we confirmed that the assay was working properly and 
there was no interaction in strain 3, even though it was expected to be, nor in the strain 4.  
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DISCUSSION 
 
    This project has emerged from a finding suggesting that EIIA
Ntr 
protein which is encoded by 
ptsN gene interacts with SsrB protein and this interaction results in negative regulation of 
Salmonella virulence (Choi et al., 2010). In the experiments done by our supervisor, a point 
mutation in ptsN gene (substitution of Ser21 with Arg21) was identified and this led to an 
evolutionary advantage over the wild type Salmonella strains. In this study, we mainly aimed to 
investigate if there is interaction between the protein encoded by point mutated ptsN (ptsN-SNP) 
and SsrB. In order to observe the protein interactions and measure the interaction levels; ptsN and 
ssrB genes were cloned into the vectors pKT25 and pUT18C respectively. On account of 
investigating the correlation between ptsN and ssrB genes by means of their protein products; 
BACTH system was used by constructing two strains with cloning (pUT18C-ssrB/pKT25-ptsN 
and pUT18C-ssrB/pKT25-ptsN-SNP). In this system, measuring β-galactosidase activity served 
as an indicator of the lacZ gene expression resulting from the presence of interaction. For 
comparison, positive (pUT18C-zip/ pKT25-zip) and negative (pUT18C/pKT25) controls were 
used in the experiment since they would indicate high and low activity respectively.  
 
Figure 13. “Input” pie chart with color 
indication stands for wild type Salmonella 
strains that were tagged with unique tags. 
After 6 weeks one strain dominated in the 
liver sample (98%) over all the other. (Pie 
charts adapted from supervisor) 
 
    In the primary experiment, mice were infected with the wild type Salmonella strains with 8 
unique 40-bp tags (Fig. 13) and after the 6 week period of infection, samples were taken from the 
liver, spleen and fecal matter. The liver sample was particularly dominated with only one strain, 
which after sequencing, was found to have a point mutation in the ptsN gene. Recent findings 
indicated that ptsN is essential for Salmonella virulence. As mentioned above, Choi, et al. 
showed that, by interacting with SsrB, EIIA
Ntr
 is repressing a virulence gene expression of SPI-2, 
therefore in this project we aimed to see if point mutation in the gene could influence protein 
interaction.  
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    According to the presented data, there is no interaction of SsrB with neither wild type or 
mutated version of EIIA
Ntr
. Also, the activity values were not as high as expected from Choi et al. 
results. In the paper, the activities were around 3000 Miller units whereas our positive results 
were around 50 Miller units. However, the difference in activity values between positive and 
negative control was clear enough to assume that the BACTH system was working properly. For 
the second trial of assay, necessary troubleshooting regarding growing conditions was done and 
β-galactosidase assay protocol was adjusted, the new strains were prepared and the presence of 
the genes of interests within the strains was confirmed through colony PCR. Due to lack of time, 
the sequencing of the amplified PCR products could not be performed. Even though the correct 
band sizes were obtained during troubleshooting, there is no 100% confidence that the genes 
were correct or did not mutate during these stages. Another issue that may be causing 
inconsistency is the primers used in the experiment. The primers presented in the Choi paper 
were not used, but new ones were designed. The primers were working during the PCR reaction, 
and amplified product had the expected size, however the exact nucleotide sequences of our PCR 
products are not known. 
    To investigate, the Choi paper was the only source which suggested that the EIIA
Ntr
 protein 
was regulating the virulence of Salmonella by interacting with SsrB. Further literature search did 
not show any connection between SsrB and EIIA
Ntr
, and it seems that research is focused on 
investigating the role of ptsN in the bacterial metabolism (Bordo et al., 1998). However, the 
function of the ptsN is mostly investigated in E.coli that, despite similarities with Salmonella, is a 
different organism and does not have SPIs. Nevertheless, suggested new functions of ptsN 
(possible regulator of potassium metabolism), are worth investigating (Reaves & Rabinowitz, 
2011). Metabolic changes may contribute indirectly to the virulence, and as presented, 
Salmonella having mutated ptsN shows definite evolutionary advantages over the wild type, as it 
eliminates other wild type strains in the mouse liver during the 6 week period of infection.  
    In order to check direct effect on the Salmonella virulence, another experiment was designed, 
but was not performed due to the lack of time. Two SPI-2 gene promoters, regulated by SsrB, 
would be fused with lacZ. ssaG, is a promoter for ssa genes, which encode for the type III 
secretion system apparatus, and sseA is a promoter for genes encoding for the secretion system 
effectors (Marcus et al., 2000). Thus, if EIIA
Ntr
-SNP influences the interaction with SsrB, it 
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would indirectly change (increase or decrease) the expression level of virulent genes, as they are 
regulated by binding of SsrB to the promoters. Expression level of these two genes would be 
measured in S. Typhimurium by β-galactosidase activity. The non-mutated EIIANtr would be used 
as a control. 
    To sum up, additional experiments should be done in order to confirm whether there is 
interaction between SsrB and EIIA
Ntr
, as we could not reproduce Choi results with the BATCH 
system experiment. Besides, even if interaction of EIIA
Ntr 
and SsrB is not affected by point 
mutation in ptsN, mutation still may influence the virulence of Salmonella by taking part in 
metabolic functions.   
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Appendix A 
 
Protocol 1: PCR for ssrB, ptsN and ptsN-SNP 
Prepare PCR mixes according to the values below in eppendorf tubes and start PCR with the 
programs given below. 
PCR mix for ssrB, ptsN and ptsN-SNP 
1µl template (chromosomal DNA from wild type or mutant Salmonella) 
1µl forward primer (20pmol/µl) 
1µl reverse primer (20pmol/µl) 
5µl 10x PCR-buffer 
1µl dNTP 
0,5µl Dream Taq polymerase 
40,5µl MQ water 
PCR program for ssrB: 
 Step1: 98oC for 5 min 
 Step2: 95oC for 30 seconds 
 Step3: 52oC for 30 seconds 
 Step4: 72oC for 60 seconds 
 Step5: 72oC for 5 min 
 Step6: cool at 4oC 
Repeat steps 2 to 4 for 30 cycles. 
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PCR program for ptsN and ptsN-SNP: 
 Step1: 98oC for 5 min 
 Step2: 95oC for 30 seconds 
 Step3: 54oC for 30 seconds 
 Step4: 72oC for 60 seconds 
 Step5: 72oC for 5 min 
 Step6: cool at 4oC 
Repeat steps 2 to 4 for 30 cycles. 
Protocol 2: Agarose gel and Electrophoresis 
Agarose gel is run to check if the correct PCR products are obtained.  
For the gel, mix 1 g of Agarose powder with 100ml of 1X TAE buffer. Then, add 10µl EtBr to 
the liquid and pour the gel. After the gel solidifies, samples can be loaded with loading dye. For 
this procedure, 2µl loading dye and 2µl purified DNA or 8µl un-purified DNA is mixed in PCR 
tube. Next, 8 µl MQ water is added. Agarose gel is run at 100V for 20 minutes. 
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Appendix B 
 
Protocol 1: CaCl2 competent E. coli-cells. 
Streak XL1-Blue and BTH101 on LB-agar plate. Incubate plate at 37ºC overnight (ON), agar up. 
1. Transfer 1 colony from a fresh plate to 5 ml LB, incubate at 37ºC ON with shaking. The 
tube should be at a 45° angle. 
2. Transfer 1 ml of ON culture to a 250ml flask with 50ml LB. Incubate at 37ºC with 
shaking. 
3. Measure OD600 every hour: Take out 1 ml, transfer to cuvette, measure OD (Blank is 1 ml 
LB). 
4. Grow until OD600 reaches 0.5-0.8. 
5. Transfer the culture to one centrifuge tube. Incubate 10 min on ice. 
6. Harvest the cells by centrifuging at 3500 rpm for 5minutes at 4ºC.  
7. Pour off the supernatant. 
8. Wash carefully (no vortexing) in 50 ml sterile ice cold 50 mM CaCl2, centrifuge again. 
Pour off the supernatant. 
9. Repeat wash. 
10. Carefully resuspend in 5 ml sterile ice cold 50 mM CaCl2, incubate on ice for 1-1½ hours.  
11. Transfer 200µl cells to sterile microfuge-tubes with 50µl 50% sterile glycerol. 
12. Store in -80ºC freezer. 
 
Protocol 2: Transformation 
1. Add DNA (10µl of ligation mix, or 2µl of plasmid DNA) to the 100 µl of competent cells, 
mix carefully, incubate on ice for 30 minutes. 
2. Heat-shock for 2.5 minutes at 42ºC. 
3. Incubate for 5 minutes on ice. 
4. Add 1 ml LB, incubate for 1 hour at 37ºC shaking. 
5. Spin cells down by centrifuging at 3500 rpm for 5 minutes, pour off the supernatant, 
resuspend in remaining supernatant, plate the cells on plates with appropriate antibiotic. 
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Appendix C 
 
Protocol 1: Digestion  
Digestion of ptsN Digestion of ptsN-SNP Digestion of pKT25 
20µl PCR product 20µl PCR product 30µl pKT25 plasmid 
5µl Fast-digest buffer 5µl Fast-digest buffer 5µl Fast-digest buffer 
1µl BamHI restriction enzyme 1µl BamHI restriction enzyme 1µl BamHI restriction enzyme 
1µl EcoRI restriction enzyme 1µl EcoRI restriction enzyme 1µl EcoRI restriction enzyme 
23µl MQ-water 23µl MQ-water 12µl MQ-water 
  1µl FastAP 
 
 
 
 
 
 
Prepare the digestion mixes which are prepared according to table above and incubated for 1hour 
at 37
o
C. 
Check if the vector has linearized by running on agarose gel with un-digested plasmid next to it, 
for comparison. 
If the vectors are correctly prepared, purify the digested PCRs and the digested vector on a spin-
column using the PCR-purification-kit. Check the resulting products on an agarose gel. 
  
Digestion of ssrB Digestion of pUT18C 
20µl PCR product 20µl pKT25 plasmid 
5µl Fast-digest buffer 5µl Fast-digest buffer 
1µl BamHI restriction enzyme 1µl BamHI restriction enzyme 
1µl EcoRI restriction enzyme 1µl EcoRI restriction enzyme 
23µl MQ-water 12µl MQ-water 
 1µl FastAP 
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Protocol 2: Ligation  
The molar ratio between vector and PCR should be 1:5, one ligation is used as control.  
pKT25-ptsN/ptsN-SNP #1 #2 #3 #4 
µl vector 2 2 2 2 
µl PCR 0 2 5 10 
µl T4-ligation buffer 2 2 2 2 
µl liagse 2 2 2 2 
µl MQ-water 14 12 9 4 
Ratio vector:PCR 2:0 1:1 1:2,5 1:5 
 
pUT18C-ssrB #1 #2 #3 #4 
µl vector 1 1 1 1 
µl PCR 0 2 5 10 
µl T4-ligation buffer 2 2 2 2 
µl liagse 2 2 2 2 
µl MQ-water 15 13 10 5 
Ratio vector:PCR 1:0 1:2 1:5 1:10 
 
Incubate ligation for 1 hour at room temperature. Transform XL1-Blue competent cells with 
ligations according to Appendix B: Protocol 2. Plate the cells with proper antibiotic and incubate 
at 37
o
C. Store the remaining ligations mix in the freezer at -20
o
C. 
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Protocol 3: Colony PCR 
Prepare mastermix for each type of PCR. 
ssrB mastermix, total volume 250µl ptsN mastermix, total volume 500µl 
5µl ssrB fwd-primer (20pmol/µl) 10µl ptsN fwd-primer (20pmol/µl) 
5µl ssrB rev-primer (20pmol/µl) 10µl ptsN rev-primer (20pmol/µl) 
115µl sterile MQ-water 230µl sterile MQ-water 
125xl Green DreamTaq Masermix 250xl Green DreamTaq Masermix 
 
Mix well by pipetting, leave on ice. 
Prepare strips of PCR-tubes. Label two strips for each clone with clone name and numbers. 
Use a clean tooth-pick to prick in one colony from streak 1 of the ssrB-clone. Put the tooth-pick 
into the appropriate PCR-tube (ssrB-1). Transfer the bacterial mass to the inside of the tube. 
When you have transferred template to all tubes, put the tubes in the microwave with lids wide 
open. Give them 1 minute at high watt. This will lyse the cells and release the DNA. 
Add 15 ul of appropriate (ssrB vs. ptsN) mastermix in each tube. 
Close the lids tightly using your thumbs and spin down briefly in the PCR-spin. 
Start the PCR, using the appropriate PCR programs for ssrB and ptsN, respectively [Appendix A, 
protocol 1]. 
After the PCR, run the products on agarose gel to check if they have the right size. The colony-
PCRs already contains loading buffer, no need to put more loading buffer on them. 
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Appendix D 
 
Protocol 1: Preparation of X-gal Plates 
To prepare X-gal plates, put 200µl ampicillin (100 µg/ml), 200µl kanamycin (50 µg/ml) and X-
gal (40 µg/ml) in 200ml of liquid LB agar. Then, pour the medium into plates. Plates should 
always be kept in dark since X-gal is light sensitive. 
Protocol 2: β-galactosidase Assay 
Preparation of Z buffer (For 500 mL): 
Mix 150 mL of  0.2 M Na2HPO4, 100 mL of 0.2 M NaH2PO4, 5 mL of 1 M KCl and5 mL 0.1M 
MgSO4 in a graduated cylinder. Add sterile MQ water until the total volume reaches 500ml. 
Adjust pH to 7 by using a pH meter. Before using the Z buffer for the assay, add β-
mercaptoethanol( 35 µl per 10 mL Z buffer) in the fume hood. 
Preparation of fresh lysis buffer ( For 9 mL): 
Mix 7.32 mL Z buffer, 1.6 mL lysozyme (2.5 mg/mL) and 80 µL of triton-X 100. 
Preparation of fresh ONPG solution: 
Z buffer with 4 mg/mL ONPG, 100µl/sample. Vortex vigorously to dissolve. Since ONPG is 
light sensitive, wrap in tin foil. 
1. Incubate overnight culture of each strain in 5ml LB+amp+kan. Incubate overnight at 37oC 
with shaking. Next day, subculture 0,5ml of each culture into 250ml flasks with fresh 
media. Measure OD. 
2. Incubate flasks with shaking. Measure OD at 600nm every hour. 
3. When OD reaches 0.3-0.5, add 0.5ml 1M IPTG. 
4. Re-incubate cultures for another hour. 
5. Measure OD (harvest OD) and proceed to harvest. 
6. Harvest 3x1ml culture in eppendorf tubes from each strain, spin down 10 min at 8000 
rpm.  
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7. Remove supernatant, store the cells in -20oC until all the samples are collected. Only two 
of the samples are used and they are the biological replicates. 
8. Re-suspend samples in 1m Z-buffer. Measure OD using 0.1ml cell suspension and 0.9ml 
sterile saline solution (0.9%) at 600nm.  
9. Transfer 50 µl of each cell-suspension to two eppendorf tube, add 450µl lysis buffer. In 
this step technical duplicates are obtained. 
10. Vortex 5 seconds. 
11. Incubate in 30oC in heat block, standing in the fume hood. 
12. Add 50µl of 4mg/ml ONPG solution. 
13. Vortex 5 seconds. Start the timer. 
14. Incubate samples in 30oC in the heat block. 
15. When the color of tube turns to yellow, add 0.5ml of 0.5M Na2CO3. Mix well to stop the 
reaction. Write down the stop time. 
16. Store the sample in the fridge until all the samples are collected. Samples should stay 180 
minutes at most even if they don’t turn yellow. 
17. Spin the samples 2 minutes at maximum speed. 
18. Transfer 200 µl to 96-well microtiter-plates. Measure OD at 420nm and 550nm, using 
ELISA-reader. Blind sample is used as blank. 
19. If OD500 is bigger than 0.05, spin the cell down and measure again. 
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Appendix E 
 
Table 1. Alignment of amino acid sequences of ptsN gene obtained from BLAST [http://www.st-
va.ncbi.nlm.nih.gov/tools/cobalt/cobalt.cgi?CMD=Get&cobaltRID=JAFADWA721S 08.04.2015], where 99 
different  organism were compared with sequence of Salmonella enterica enterica serovar Typhimurium str. ST4/74, 
obtained from BioCyc database, in order to check conservation of Ser21. Table does not show whole amino acid 
sequence, just the first part from 1-72 or 1-80, where Ser21 was expected to be found. Some organism shown longer 
protein sequence, therefore corresponding position for serine would be 29. Some organism are found to have alanine 
instead of serine on position 21. Serine is indicated as S and marked with red on the position of interest and alanine is 
indicated as A and marked with green on the position of interest. BLAST engine does not indicated exact strain nor 
genus for all of the presented organism, however NCBI reference sequence (ref seq in the table) should lead to the 
corresponding organism.  
 
Organism  NCBI ref seq Peptide sequence 1-50 (or 1-58) 
Salmonella enterica 
enterica serovar 
Typhimurium str. 
ST4/74 
Obtained from biocyc.org 
[08.04.2015] 
--------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella enterica WP_000609332 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella enterica WP_024155356 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella enterica WP_023193803 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella enterica WP_000609329 --------MINNDTTLQLSGVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella enterica WP_000609330 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella bongori WP_000609333 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella enterica WP_023238078 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia fergusonii WP_000609334 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella enterica WP_000609331 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter WP_042325036 --------MINNDTTLQLSSVLNQECTRSAVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter koseri WP_012135337 --------MTNNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter sedlakii WP_042291903 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQIV 
Salmonella enterica 
subsp. enterica 
serovar Enteritidis 
str. SA20100349 
AHT97447 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVX 
Escherichia WP_000609337 --------MINNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Leclercia 
adecarboxylata 
WP_032614485 --------MMNNDSTLQLSSVLNQECTRSAVHCQSKKRALEIISELAAKQLSLPPQVV 
Leclercia 
adecarboxylata 
WP_039031625 --------MMNNDSTLQLSSVLNQECTRSAVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia albertii WP_000609335 --------MINNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia WP_000609336 --------MINNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_000183678 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_032208173 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter sp. CIP 
55.13 
WP_005121328 --------MTNNDTTLQLSNVLNQECTRAAVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter freundii WP_032945121 --------MTNNDTTLQLSTVLNQECTRAGVHCQSKKRALEIISELAAKQLSLPAQVV 
Citrobacter WP_003025083 --------MTNNDTTLQLSTVLNQECTRAGVHCQSKKRALEIISELAAKQLSLPSQVV 
Escherichia coli WP_014641134 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacteriaceae WP_000183676 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter werkmanii WP_042311297 --------MINNDTTLQLSNVLNQECTRAAVHCQSKKRALEIISELAAKQLSLPSQVV 
Escherichia coli WP_001600542 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001331180 --------MTNNDTTLQLSSVLNRECTRSRIHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_021543068 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Enterobacteriaceae WP_007369895 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLGLPPQVV 
Shigella dysenteriae WP_000532375 mgrflgeiMTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Klebsiella pneumoniae 
IS22 
CDK70724 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter rodentium WP_012908510 --------MINNDTTLQLNSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_028132089 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
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Escherichia WP_000183679 --------MTNNDTTLQLSTVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter freundii WP_019077788 --------MTNNDTTLQLSNVLNQECTRAGVHCQSKKRALEIISELAAKQLSLPSQVV 
Escherichia coli WP_001364896 --------MTNNDTTLQLSSVLNRECTRSRLHCQSKKRALEIISELAAKQLSLPPQVV 
Shigella dysenteriae WP_000183673 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISDLAAKQLSLPPQVV 
Escherichia coli WP_001498581 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_000183677 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001301839 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_032177619 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001652178 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Citrobacter freundii WP_044714527 --------MTNNDTTLQLSTVLNQECTRAAVHCQSKKRALEIISELAAKQLSLPSQVV 
Escherichia coli WP_001571965 --------MTNNNTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001299132 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001348315 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacter sp. 
Bisph2 
WP_039077448 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacter sp. 638 WP_015960621 --------MMNNDSGLQLSHVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli KFH98932 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_033545869 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Shigella dysenteriae 
1617 
AHA67322 mgrflgeiMTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISDLAAKQLSLPPQVV 
Escherichia coli WP_033810500 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSMPPQVV 
Escherichia coli WP_001400765 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001390716 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacteriaceae WP_006687857 --------MTNNDTTLQLSNVLNQECTRAAVHCQSKKRALEIISELAAKQLSLPSQVV 
Shigella flexneri WP_005103796 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001458286 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacteriaceae WP_017457319 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLGLPPQVV 
Escherichia coli WP_001303151 --------MTNNDTTLQLSTVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli KFH78280 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Shigella flexneri WP_039070374 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Shigella sonnei WP_005140261 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001570354 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacter WP_013098944 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLGLPPQVV 
Escherichia coli WP_003912187 --------MTNNDTTLQLSSVLNRECTRSRIHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001469383 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001679623 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQGV 
Citrobacter WP_016154690 --------MTNNDTTLQLSNVLNQECTRAGVHCQSKKRALEIISELAAKQLSLPSQVV 
Escherichia WP_000183674 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Enterobacter asburiae WP_029739614 --------MMNNDSALQLSNVLNQECTRSAVHCQSKKRALEIISELAAKQLGLPPQVV 
Enterobacteriaceae WP_003861869 --------MINNDSALQLSNVLNQDCTRSGVHCQSKKRALEIISELAAKQLGLPPQIV 
Escherichia coli WP_001359909 --------MTNNDTTLQLSNVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_001300596 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_003922710 --------MTNNDTTLQLSSVLNRECTRSRINCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacter cloacae 
complex 
WP_006812138 --------MINNDSALQLSNVLNQDCTRSGVHCQSKKRALEIISELAAKQLGLPPQIV 
Enterobacter cloacae WP_014833457 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLGLPPQVV 
Escherichia coli WP_042021101 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Enterobacter sp. 
Bisph1 
WP_039056782 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLGLPPQVV 
Escherichia coli WP_039021338 --------MTNNDTTPQLSTVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_000532369 mgrflgeiMTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Escherichia coli WP_001733395 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_042091473 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Escherichia coli WP_021545328 --------MTNNDTTLQISSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Escherichia vulneris WP_042390072 --------MMNNDPALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Salmonella enterica 
subsp. enterica 
serovar Enteritidis 
str. EC20120051 
AHS42100 --------MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLXXXXXXX 
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Citrobacter freundii] WP_038634278 --------MTNNDTTLQLSNVLNQECTRAAVHCQSKKRALEIISELAAKQLSLPSQVV 
Escherichia coli WP_044707211 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Escherichia coli WP_001588776 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQMV 
Yokenella regensburgei WP_006818097 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacter cloacae 
complex 
WP_014171819 --------MMNNDSALQLSNVLNQECTRSAVHCQSKKRALEIISELAAKQLGLPPQVV 
Escherichia coli WP_000183675 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVV 
Enterobacteriaceae WP_023480947 --------MMNNDSALQLSTVLNQECTRSGVHCQSKKRALEIISELAAKQLGLPPQVV 
Enterobacter 
cancerogenus 
WP_006178791 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLGLPPQLV 
Enterobacter 
massiliensis 
WP_044179578 --------MMNNDSALQLSNVLNQECTRSAVHCQSKKRALEIISELAAKQLSLPPQVV 
Escherichia coli WP_031319458 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Enterobacter  WP_010436064 --------MMNNDSALQLSNVLNQECTRSGVHCQSKKRALEIISELAAKQLGLPPQVV 
Escherichia coli WP_033556248 --------MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLAPQVV 
Enterobacter  WP_008501443 --------MMNNDSALQLSNVLNQECTRSAVHCQSKKRALEIISELAAKQLGLPPQVV 
 
 
Table 2. Alignment of ptsN amino acid sequence between Escherichia coli K-12 substr. MG1655 (used in Bordo et 
al., 1998) and Salmonella enterica enterica serovar Typhimurium str. ST4/74. Differences in the sequence are 
indicated in red. Both sequences are obtained from biocyc.org and align at 
http://www.ebi.ac.uk/Tools/services/web/toolresult.ebi?jobId=clustalw2-I20150521-094151-0296-14507790-pg 
(08.04.2014). 
Organism Position Amino acid sequence 
E.coli 1-60 MTNNDTTLQLSSVLNRECTRSRVHCQSKKRALEIISELAAKQLSLPPQVVFEAILTREKM 
Salmonella  MINNDTTLQLSSVLNQECTRSGVHCQSKKRALEIISELAAKQLSLPPQVVFEAILTREKM 
E.coli 61-120 GSTGIGNGIAIPHGKLEEDTLRAVGVFVQLETPIAFDAIDNQPVDLLFALLVPADQTKTH 
Salmonella  GSTGIGNGIAIPHGKLEEDTLRAVGVFVQLETPIAFDAIDNQPVDLLFALLVPADQTKTH 
E.coli 121-163 LHTLSLVAKRLADKTICRRLRAAQSDEELYQIITDTEGTPDEA 
Salmonella  LHTLSLVAKRLADKTICRRLRAALNDEELYQIITDTEGEQNEA 
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Appendix F 
 
Table 1.The OD readings, β-galactosidase activities and stopping time of experiment for the first trial. Coding 
system for the name of strains is as follows: the first number after # is the strain name and the second number is for 
the biological replicates as we made the experiment with two different colonies. There are also technical replicates 
which are derived from the same colony and they are indicated as 1 and 2 in the table. Averages of these values are 
given in the right column.  #1.1 indicates the strain 1(negative control) and biological replicate 1, and so on. 
 
  
Strains OD420 OD550 OD600 Time(min) Activity 
1 2 Average 1 2 Average    
#1.1 0,107 0,109 0,108 0,004 0,005 0,0045 4,63 150 1,44 
#1.2 0,079 0,066 0,073 0,006 0,005 0,0055 2,59 150 1,63 
#1.3 0,139 0,128 0,134 0,005 0,005 0,005 1,24 76 13,29 
#2.1 0,054 0,053 0,054 0,004 0,003 0,0035 2,93 150 1,11 
#2.2 0,075 0,072 0,074 0,004 0,005 0,0045 2,81 150 1,56 
#2.3 0,146 0,157 0,15 0,005 0,006 0,0055 1,34 76 13,78 
#3.1 0,077 0,085 0,081 0,005 0,005 0,005 3,93 150 1,22 
#3.2 0,08 0,071 0,076 0,005 0,004 0,0045 4,94 150 0,92 
#3.3 0,156 0,153 0,155 0,007 0,005 0,006 1,03 52 26,98 
#4.1 0,085 0,088 0,087 0,004 0,004 0,004 7,46 150 0,71 
#4.2 0,072 0,068 0,07 0,004 0,006 0,005 5,55 150 0,73 
#4.3 0,217 0,152 0,185 0,008 0,007 0,0075 1,06 76 21,33 
37 
 
Table 2.The OD readings, β-galactosidase activities and stopping time of experiment for the second trial. Coding 
system for the name of strains is as follows: the first number after # is the strain name and the second number is for 
the biological replicates as we made the experiment with two different colonies. There are also technical replicates 
which are derived from the same colony and they are indicated as 1 and 2 in the table. Averages of these values are 
given in the right column.  #1.1 indicates the strain 1(negative control) and biological replicate 1, and so on. 
 
 
  
Strains OD420 OD550 OD600 Time(min) Activity 
1 2 Average 1 2 Average       
#1.1 0,016 0,016 0,016 0,003 0,003 0,003 0,34 120 2,63 
#1.2 0,02 0,019 0,0195 0,002 0,002 0,002 0,61 120 2,185 
#2.1 0,19 0,21 0,2 0,004 0,004 0,004 0,27 120 59,57 
#2.2 0,205 0,19 0,1975 0,004 0,003 0,0035 0,35 120 45,56 
#3.1 0,011 0,019 0,015 0,003 0,004 0,0035 0,42 120 1,76 
#3.2 0,019 0,017 0,018 0,003 0,003 0,003 0,57 120 1,864 
#4.1 0,016 0,018 0,017 0,003 0,003 0,003 0,5 120 1,96 
#4.2 0,016 0,017 0,0165 0,004 0,007 0,0055 0,47 120 1,22 
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